Top Banner
No materials in this presentation may be repurposed in print or online without the express written permission of the American Joint Committee on Cancer. Permission requests may be submitted at cancerstaging.org. Validating science. Improving patient care. AJCC Staging Moments AJCC TNM Staging 8th Edition Melanoma Case #1
21

AJCC Staging Moments Case 1.pdf · – cTis for melanoma in situ – cN0 because nodes were clinically negative on physical exam* – cM0 because there were no signs or symptoms to

Feb 03, 2020

Download

Documents

dariahiddleston
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: AJCC Staging Moments Case 1.pdf · – cTis for melanoma in situ – cN0 because nodes were clinically negative on physical exam* – cM0 because there were no signs or symptoms to

No materials in this presentation may be repurposed in print or online without the express written permission of the American Joint Committee on Cancer. Permission requests may be submitted at cancerstaging.org.

Validating science. Improving patient care.

AJCC Staging Moments AJCC TNM Staging 8th Edition Melanoma Case #1

Page 2: AJCC Staging Moments Case 1.pdf · – cTis for melanoma in situ – cN0 because nodes were clinically negative on physical exam* – cM0 because there were no signs or symptoms to

Contributors: Jeffrey E. Gershenwald, MD, FACS The University of Texas MD Anderson Cancer Center Houston, Texas

Page 3: AJCC Staging Moments Case 1.pdf · – cTis for melanoma in situ – cN0 because nodes were clinically negative on physical exam* – cM0 because there were no signs or symptoms to

Copyright © 2018 AJCC All Rights Reserved 3

Melanoma Case # 1 Presentation of New Case

• Newly diagnosed melanoma patient

• Presentation at Cancer Conference for treatment recommendations and clinical staging

Page 4: AJCC Staging Moments Case 1.pdf · – cTis for melanoma in situ – cN0 because nodes were clinically negative on physical exam* – cM0 because there were no signs or symptoms to

Copyright © 2018 AJCC All Rights Reserved 4

Melanoma Case # 1 History & Physical

• 83 yr old female who presented with 2 cm maximal diameter brown lesion right cheek over right malar eminence; no clinical evidence of ulceration, cervical lymphadenopathy, in-transit or satellite disease

• No family hx of melanoma

Used with permission. Marghoob A, Halpern A. Atlas of Cancer. Edited by Maurie Markman, Ashfaq A. Marghoob. ©2002 Current Medicine, Inc.

Used with permission. Marghoob A, Halpern A. Atlas of Cancer. Edited by Maurie Markman, Ashfaq A. Marghoob. ©2002 Current Medicine, Inc.

Page 5: AJCC Staging Moments Case 1.pdf · – cTis for melanoma in situ – cN0 because nodes were clinically negative on physical exam* – cM0 because there were no signs or symptoms to

Copyright © 2018 AJCC All Rights Reserved 5

Melanoma Case # 1 Imaging Results

• No imaging

Page 6: AJCC Staging Moments Case 1.pdf · – cTis for melanoma in situ – cN0 because nodes were clinically negative on physical exam* – cM0 because there were no signs or symptoms to

Copyright © 2018 AJCC All Rights Reserved 6

Melanoma Case # 1 Diagnostic Procedure

• Diagnostic Procedure – Excision skin lesion right cheek

• Pathology Report

– Melanoma in situ – Lentigo maligna type – Peripheral margin involved

Page 7: AJCC Staging Moments Case 1.pdf · – cTis for melanoma in situ – cN0 because nodes were clinically negative on physical exam* – cM0 because there were no signs or symptoms to

Copyright © 2018 AJCC All Rights Reserved 7

Melanoma Case # 1 Clinical Staging

• Clinical staging – Uses information from physical exam, imaging, and diagnostic

biopsy including excision of primary tumor in melanoma – Excision of primary tumor includes shave bx, punch bx, incisional

bx, excisional bx, or complete excisional bx (microstaging)

• Purpose – Select appropriate treatment – Estimate prognosis

Page 8: AJCC Staging Moments Case 1.pdf · – cTis for melanoma in situ – cN0 because nodes were clinically negative on physical exam* – cM0 because there were no signs or symptoms to

Copyright © 2018 AJCC All Rights Reserved 8

Melanoma Case # 1 Clinical Staging

• Synopsis: patient with melanoma in situ with involved peripheral margin, no clinical lymphadenopathy

• What is the clinical stage? – T____ – N____ – M____ – Stage Group______

Page 9: AJCC Staging Moments Case 1.pdf · – cTis for melanoma in situ – cN0 because nodes were clinically negative on physical exam* – cM0 because there were no signs or symptoms to

Copyright © 2018 AJCC All Rights Reserved 9

Melanoma Case # 1 Clinical Staging

• Clinical Stage correct answer – cTis – cN0 – cM0 – Stage Group 0

• Based on stage, treatment is selected

• Review treatment guidelines for this stage

Page 10: AJCC Staging Moments Case 1.pdf · – cTis for melanoma in situ – cN0 because nodes were clinically negative on physical exam* – cM0 because there were no signs or symptoms to

Copyright © 2018 AJCC All Rights Reserved 10

Melanoma Case # 1 Clinical Staging

• Rationale for staging choices – cTis for melanoma in situ

– cN0 because nodes were clinically negative on physical exam*

– cM0 because there were no signs or symptoms to suggest distant

metastases*

– * Additional tests would likely be performed if evidence of regional or distant disease before developing a treatment plan

Page 11: AJCC Staging Moments Case 1.pdf · – cTis for melanoma in situ – cN0 because nodes were clinically negative on physical exam* – cM0 because there were no signs or symptoms to

Copyright © 2018 AJCC All Rights Reserved 11

Melanoma Case # 1 Treatment Options

• Review treatment guidelines for this stage

• Discuss appropriate treatment plans for this patient

Page 12: AJCC Staging Moments Case 1.pdf · – cTis for melanoma in situ – cN0 because nodes were clinically negative on physical exam* – cM0 because there were no signs or symptoms to

Copyright © 2018 AJCC All Rights Reserved 12

Melanoma Case # 1 Surgery & Findings

• Surgery – Re-excision with 5mm margin

• Operative findings

– No contributory information

Page 13: AJCC Staging Moments Case 1.pdf · – cTis for melanoma in situ – cN0 because nodes were clinically negative on physical exam* – cM0 because there were no signs or symptoms to

Copyright © 2018 AJCC All Rights Reserved 13

Melanoma Case # 1 Pathology Results

• Residual melanoma in situ

• Lentigo maligna melanoma

• Extends close to, but does not involve, radial margins; deep margins uninvolved

Page 14: AJCC Staging Moments Case 1.pdf · – cTis for melanoma in situ – cN0 because nodes were clinically negative on physical exam* – cM0 because there were no signs or symptoms to

Copyright © 2018 AJCC All Rights Reserved 14

Melanoma Case # 1 Pathological Staging

• Pathological staging – Uses information from clinical staging, operative findings, and

resected specimen pathology report

• Purpose – Additional precise data for estimating prognosis – Calculating end results (survival data)

Page 15: AJCC Staging Moments Case 1.pdf · – cTis for melanoma in situ – cN0 because nodes were clinically negative on physical exam* – cM0 because there were no signs or symptoms to

Copyright © 2018 AJCC All Rights Reserved 15

Melanoma Case # 1 Pathological Staging

• Synopsis: patient with melanoma in situ, no nodes removed, clinically nodes negative

• What is the pathological stage? • T____

– N____ – M____ – Stage Group______

Page 16: AJCC Staging Moments Case 1.pdf · – cTis for melanoma in situ – cN0 because nodes were clinically negative on physical exam* – cM0 because there were no signs or symptoms to

Copyright © 2018 AJCC All Rights Reserved 16

Melanoma Case # 1 Pathological Staging

• Pathological Stage - correct answer – pTis – cN0 – cM0 – Stage Group 0

Page 17: AJCC Staging Moments Case 1.pdf · – cTis for melanoma in situ – cN0 because nodes were clinically negative on physical exam* – cM0 because there were no signs or symptoms to

Copyright © 2018 AJCC All Rights Reserved 17

Melanoma Case # 1 Pathological Staging

• Rationale for staging choices – pTis for melanoma in situ

– cN0 because of exception for pathological Stage 0 and pT1

they do not require microscopic evaluation of nodes

– cM0 – use clinical M with pathological staging unless there is microscopic confirmation of distant metastasis

Page 18: AJCC Staging Moments Case 1.pdf · – cTis for melanoma in situ – cN0 because nodes were clinically negative on physical exam* – cM0 because there were no signs or symptoms to

Copyright © 2018 AJCC All Rights Reserved 18

Prognostic Factors/Registry Data Collection

• Applicable to this case

– Primary tumor thickness: not applicable

– Ulceration: not applicable

Page 19: AJCC Staging Moments Case 1.pdf · – cTis for melanoma in situ – cN0 because nodes were clinically negative on physical exam* – cM0 because there were no signs or symptoms to

Copyright © 2018 AJCC All Rights Reserved 19

Tis – melanoma in situ

Melanoma. In Compton, C.C., Byrd, D.R., et al. (Eds.) AJCC Cancer Staging Atlas, 2nd edition (2012)

Page 20: AJCC Staging Moments Case 1.pdf · – cTis for melanoma in situ – cN0 because nodes were clinically negative on physical exam* – cM0 because there were no signs or symptoms to

Copyright © 2018 AJCC All Rights Reserved 20

Melanoma Case # 1 Recap

• Summary of correct answers

– Clinical stage - cTis cN0 cM0 Stage Group 0

– Pathological stage - pTis cN0 cM0 Stage Group 0

• Staging classifications each have a different purpose and

method of assessment so can be different. Do not go back and change the clinical staging based on pathological staging information.

Page 21: AJCC Staging Moments Case 1.pdf · – cTis for melanoma in situ – cN0 because nodes were clinically negative on physical exam* – cM0 because there were no signs or symptoms to

Copyright © 2018 AJCC All Rights Reserved 21

Staging Moments Summary

• Review site-specific information if needed

• Clinical Staging – Based on information before treatment – Used to select treatment options

• Pathological Staging

– Based on clinical data PLUS operative findings and resected specimen pathology report

– Used to evaluate end results (e.g. survival)